(2020). CRISPR/Cas13: A potential therapeutic option of COVID-19.
Chicago Style (17th ed.) CitationCRISPR/Cas13: A Potential Therapeutic Option of COVID-19. 2020.
MLA (8th ed.) CitationCRISPR/Cas13: A Potential Therapeutic Option of COVID-19. 2020.
Warning: These citations may not always be 100% accurate.